The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Outcomes in patients with unresected glioblastoma including assessment of treatment with bevacizumab as a component of initial therapy.
Stuart Burri
Honoraria - Novocure
Ashley Love Sumrall
Honoraria - Novocure
Renee P Kelly
No relevant relationships to disclose
Peggy O Boltes
No relevant relationships to disclose
Daniel Ernest Haggstrom
No relevant relationships to disclose
Roshan Sudhir Prabhu
No relevant relationships to disclose
Mark D Smith
No relevant relationships to disclose
William E Ballinger
No relevant relationships to disclose
James Thomas Symanowski
No relevant relationships to disclose
Robert W. Fraser
No relevant relationships to disclose
Anthony L. Asher
No relevant relationships to disclose